techcrunch
PublishedAugust 29, 2026 at 5:36 PM
—neutral
“We’re not doing 30 bets a year”: Vijay Pande on betting small after running $4 billion at a16z
Publisher summary· verbatim
Vijay Pande — who left a16z's roughly $4 billion biotech practice last year to start the much smaller, AI-native VZVC — talks about why biology is finally shifting from a "discovery" science to an "engineering" one, why clinical trials are still brutally expensive, and why he thinks open, shared dat
Stay posted· Newsletter
A 5-min weekly brief — top movers, price watch, story of the week.
Discussion
No replies yet. Be first.
The Bubble Brief
WEEKLYRead AI insights every Tuesday — top movers, new releases, story of the week.
Originally published on techcrunch ↗